Search Results
May 01, 2026, 16:05 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients with Classic Congenital Adrenal Hyperplasia
of cases, aldosterone. Because individuals with CAH are typically still able to produce androgens, the unused precursors that would normally be used to make cortisol instead result in the production of excess amounts of androgens. If left untreated, CAH can result in adrenal crisis and even death.Exogenous
More news about: Neurocrine Biosciences, Inc.
Apr 30, 2026, 06:45 ET Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook
billionDUBLIN, Ohio, April 30, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025.Third
More news about: Cardinal Health, Inc.
Apr 22, 2026, 16:05 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adrenal Hyperplasia
commonly develop with traditional CAH treatment regimens. The two-year findings provide important information on the durable benefit of treatment with CRENESSITY. Providers can confidently incorporate this additional knowledge to guide their management of adult patients with CAH into the future."Neurocrine
More news about: Neurocrine Biosciences, Inc.
Apr 14, 2026, 07:00 ET Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings
homes.DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy
More news about: Cardinal Health
Apr 06, 2026, 07:00 ET Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Huntington's disease, with $2.51 billion in 2025 revenue; CRENESSITY®, approved in December 2024 for the treatment of classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, with $301 million in 2025 revenue; and VYKAT XR, approved in March 2025 for the treatment of PWS, with $190 million
More news about: Neurocrine Biosciences, Inc.
Mar 24, 2026, 06:45 ET Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30
DUBLIN, Ohio, March 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the opening of trading on the
More news about: Cardinal Health, Inc.
Mar 23, 2026, 06:45 ET Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair
DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's
More news about: Cardinal Health
Feb 24, 2026, 07:00 ET Cardinal Health report highlights cost savings and provider confidence in biosimilars
gains.DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings
More news about: Cardinal Health
Feb 12, 2026, 16:45 ET Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of
More news about: Cardinal Health
Feb 05, 2026, 06:45 ET Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook
range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter
More news about: Cardinal Health, Inc.
Feb 02, 2026, 07:00 ET WellCare of Kentucky Awards Owen County Public Transit $20,000
our community. The Golden Triangle is based on the National Rural Health Association (NRHA) model of collaboration between Critical Access Hospitals (CAH) and Federally Qualified Health Centers (FQHC) to address health disparities.
More news about: WellCare of Kentucky
Jan 06, 2026, 06:45 ET Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5
DUBLIN, Ohio, Jan. 6, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the New York Stock Exchange.
More news about: Cardinal Health, Inc.
Nov 04, 2025, 16:45 ET Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend
More news about: Cardinal Health
Nov 03, 2025, 08:30 ET Cardinal Health completes acquisition of Solaris Health
DUBLIN, Ohio, Nov. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has completed its acquisition of Solaris Health, the country's leading urology MSO. Solaris Health brings more than 750 providers
More news about: Cardinal Health
Oct 30, 2025, 07:30 ET TIGA Analysis Reveals that the Number of People Studying Video Games has Skyrocketed Over the Last 10 years
2023/24 academic year across all UK higher education (HE) providers in the subject area 'Computer games and animation' (common aggregation hierarchy (CAH) subject code 11-01-06). This compares to 4,065 undergraduate enrolments in the 2013/14 academic year across all UK HE providers
More news about: TIGA
Oct 30, 2025, 06:45 ET Cardinal Health Reports First Quarter Fiscal Year 2026 Results and Raises Outlook
DUBLIN, Ohio, Oct. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First quarter
More news about: Cardinal Health, Inc.
Oct 29, 2025, 14:39 ET EqualizeRCM Champions Rural Healthcare Through Its CAH Forum Series
"It has been exciting to moderate the CAH Forum for the past five years, and deliver fresh education to rural hospital executives," said Chris Ekrem, FACHE, VP at EqualizeRCM, CAH Forum moderator, and former CAH CEO. "The CAH forum has been one of the groups I try
More news about: EqualizeRCM
Sep 30, 2025, 09:07 ET Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
DUBLIN, Ohio, Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical
More news about: Cardinal Health
Sep 23, 2025, 06:45 ET Cardinal Health to Announce First-Quarter Results for Fiscal Year 2026 on October 30
DUBLIN, Ohio, Sept. 23, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2026 on October 30, prior to the opening of trading
More news about: Cardinal Health, Inc.
Sep 15, 2025, 12:00 ET Cardinal Health Unveils State-of-the-Art Consumer Health Logistics Center
DUBLIN, Ohio, Sept. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today is showcasing its newly operational Consumer Health Logistics Center, a 350,000-square-foot facility in Groveport,
More news about: Cardinal Health
Sep 13, 2025, 23:09 ET Suki Waterhouse, Natasha Lyonne, Devin Booker, Sean Kaufman, Ciara Miller, D-Nice, Kitty Ca$h and More Stun at Target's NYFW Style Tailgate
multimedia:https://www.prnewswire.com/news-releases/suki-waterhouse-natasha-lyonne-devin-booker-sean-kaufman-ciara-miller-d-nice-kitty-cah-and-more-stun-at-targets-nyfw-style-tailgate-302555764.html
More news about: Target Corporation